biOasis Technologies Inc. (TSX VENTURE:BTI)(OTCQX:BIOAF), a pioneering
biopharmaceutical company focused on overcoming the limitations of therapeutic
drug delivery across the blood-brain barrier, announces the appointment of Ms.
Judi Dalling as its Chief Financial Officer and Corporate Secretary effective
immediately. Ms. Dalling is an experienced professional, a graduate of The
University of British Columbia Faculty of Law who also has a strong accounting
background, having been controller and business manager of a major magazine
publishing enterprise for over 20 years. Ms. Dalling currently works with
various reporting companies, providing legal, accounting and administration
services.


Mr. David Clark has resigned as the CFO, Corporate Secretary and director of the
Company effective immediately. The Board of Directors thanks Mr. Clark for his
contributions and wishes him well in his future endeavors. Mr. Clark will be
assisting with the transition.


On Behalf of the Board of Directors

Rob Hutchison Chairman & CEO 

"Neither the TSX Venture Exchange nor its Regulation Services Provider (as that
term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release"


FOR FURTHER INFORMATION PLEASE CONTACT: 
biOasis Technologies Inc.
Tiffany Tolmie
778-383-3280 local 103
tiffany@bioasis.ca
BiOasis Technologies (TSXV:BTI)
Historical Stock Chart
From Jan 2025 to Feb 2025 Click Here for more BiOasis Technologies Charts.
BiOasis Technologies (TSXV:BTI)
Historical Stock Chart
From Feb 2024 to Feb 2025 Click Here for more BiOasis Technologies Charts.